))
Ep 14 - A Conversation with John Mumm (Deka Biosciences)
Manage episode 419850794 series 3478712
Content provided by Scheer Partners. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Scheer Partners or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
John Mumm brings over 20 years of experience in academia and the biotechnology/pharmaceutical industry, having held positions of increasing responsibility. His primary focus has been on discovery research at the interface between cancer biology and the adaptive immune response. John has significant expertise in understanding what tumors secrete that negatively impacts the immune response and developing therapeutic strategies to overcome these barriers.
He has accumulated substantial experience in translational research, particularly in rendering cytokines into therapeutic entities. Recently, John has directed his efforts toward the manufacturing of biologics for Phase 1 and 2 immuno-oncology clinical trials. His specialties include Discovery Research, Biologics Manufacturing, Oncology: Immune Interface, Cytokine Biology, and Translational Research.
21 episodes
Share
